![Jeffrey Poulton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Poulton
Director of Finance/CFO at
ALNYLAM PHARMACEUTICALS, INC.
Net worth: 19 M $ as of 2026-06-29
Profile
Mr. Jeffrey V. Poulton is an Independent Director at Homology Medicines, Inc. and a Chief Financial & Accounting Officer at Alnylam Pharmaceuticals, Inc. He is on the Board of Directors at Homology Medicines, Inc., Alnylam UK Ltd. and EIP Pharma, Inc. Mr. Poulton was previously employed as a Chief Financial Officer by Indigo Agriculture, Inc. and a Chief Financial Officer & Executive Director by Shire Plc. He received his undergraduate degree from Duke University and an MBA from Kelley School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-03 | 61,862 ( 0.05% ) | 19 M $ | 2026-06-29 | |
CERVOMED INC. 0.12% | 2026-06-07 | 16,444 ( 0.12% ) | 50 976 $ | 2026-06-29 |
Jeffrey Poulton active positions
| Companies | Position | Start |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Director of Finance/CFO | 2019-08-12 |
| CERVOMED INC. | Director/Board Member | 2023-08-15 |
EIP Pharma, Inc.
 EIP Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company focused on developing treatments for neurodegenerative diseases | Director/Board Member | - |
Alnylam UK Ltd.
 Alnylam UK Ltd. BiotechnologyHealth Technology Develops biotechnology products | Director/Board Member | 2019-08-12 |
Former positions of Jeffrey Poulton
| Companies | Position | End |
|---|---|---|
Indigo Ag, Inc.
 Indigo Ag, Inc. Chemicals: AgriculturalProcess Industries Develops biological microbial seed treatments | Director of Finance/CFO | 2019-03-31 |
| SHIRE | Director of Finance/CFO | 2014-12-31 |
| Q32 BIO INC. | Director/Board Member | - |
Training of Jeffrey Poulton
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
76
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Kelley School of Business
 Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indigo Ag, Inc.
Indigo Ag, Inc. Chemicals: AgriculturalProcess Industries Develops biological microbial seed treatments | Process Industries |
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company focused on developing treatments for neurodegenerative diseases | Health Technology |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage genetic medicines company | Health Technology |
Alnylam UK Ltd.
Alnylam UK Ltd. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
CervoMed, Inc.
 CervoMed, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops novel therapies | Commercial Services |
- Stock Market
- Insiders
- Jeffrey Poulton
